|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 Massachusetts Avenue, NW |
Address2 | Suite 320 |
| City | Washington |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1650-12
|
||||||||
|
6. House ID# 317150000
|
||||||||
| TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Ingrida Lusis |
Date | 4/13/2023 10:36:56 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
SHARE Act of 2024 (HR 1310) - Issues pertaining to healthcare workforce shortages
Medications for the Treatment of Opioid Use Disorder (87 FR 77330) - Issues pertaining to CRNAs and opioid treatment programs
Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation (88 FR 12875) - issues pertaining to CRNAs
Request for Information on Creating a National Healthcare System Action Alliance to Advance Patient Safety (87 FR 76046)- Issues pertaining to anesthesia and pain management
Request for Information on Essential Health Benefits (87 FR 74097)- Issues pertaining to provider nondiscrimination and Enhanced Recovery After Surgery (ERAS)
Surprise Billing
CRNA Scope of Practice
CRNA Reimbursement
Rural Healthcare
Extension of CMS waivers beyond public health emergency
Nursing/healthcare Workforce
Opioid Epidemic/Opioid-sparing treatments/MATs
NOPAIN Act Implementation
Provider nondiscrimination
Substance Use Disorder and mental health
Telehealth
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), White House Office, Substance Abuse & Mental Health Services Administration (SAMHSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Randi |
Gold |
|
|
|
Romy |
Gelb-Zimmer |
|
|
|
Matt |
Thackston |
|
|
|
JP |
Mason |
|
|
|
Catharine |
Harris |
|
|
|
Ingrida |
Lusis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
VA National Standards of Practice - Issues pertaining to CRNA practice and the aggregate pay limit
Reimbursement for VA CRNAs
Full Practice Authority for VA CRNAs
Telehealth
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Randi |
Gold |
|
|
|
Romy |
Gelb-Zimmer |
|
|
|
Matt |
Thackston |
|
|
|
JP |
Mason |
|
|
|
Catharine |
Harris |
|
|
|
Ingrida |
Lusis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Saving Americas Rural Hospitals Act (HR 833) - Issues pertaining to CRNA practice
Improving Care and Access to Nurses Act (pending introduction)- issues pertaining to removing barriers to APRNs
Medicare Program; Contract Year 2024 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, Medicare Parts A, B, C, and D Overpayment Provisions of the Affordable Care Act and Programs of All-Inclusive Care for the Elderly; Health Information Technology Standards and Implementation Specifications (87 FR 79452) - Issues pertaining to CRNAs, improving healthcare access, MA Plan criteria, and access to non-opioid acute pain management in Part D.
Extending/making permanent certain temporary waivers put in place during the Public Health Emergency
Medicare Reimbursement
CRNA Scope of Practice
Rural Healthcare issues
Medicare teaching rules
Provider nondiscrimination
Medicare Local Coverage Determination process
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Romy |
Gelb-Zimmer |
|
|
|
Randi |
Gold |
|
|
|
Matt |
Thackston |
|
|
|
JP |
Mason |
|
|
|
Catharine |
Harris |
|
|
|
Ingrida |
Lusis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY24 Labor-HHS Appropriations funding- Issues pertaining to increased funding for Title VIII Nursing Workforce Development, provider nondiscrimination, and CRNA practice
FY 24 Military Construction-VA Appropriations funding - Issues pertaining to CRNA practice in the VA
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
JP |
Mason |
|
|
|
Matthew |
Thackston |
|
|
|
Romy |
Gelb Zimmer |
|
|
|
Randi |
Gold |
|
|
|
Ingrida |
Lusis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
FY24 National Defense Authorization Act - Issues pertaining to provider nondiscrimination in Tricare
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matthew |
Thackston |
|
|
|
JP |
Mason |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |